comparemela.com
Home
Live Updates
Clinical Fellow - Breaking News
Pages:
3
4
5
6
7
8
9
Page 2 - Clinical Fellow News Today : Breaking News, Live Updates & Top Stories | Vimarsana
ASCO 2024: Camrelizumab plus Apatinib for Previously Treated Advanced Adrenocortical Carcinoma: A Single-Arm, Open-Label, Phase 2 Trial
advanced adrenocortical carcinoma, camrelizumab, Apatinib, Camrelizumab plus Apatinib.
United states
Zhigong wei
Society of urologic oncology
American society of clinical oncology
University of toronto
Sichuan university
Department of biotherapy
Cancer center
Clinical oncology
Annual meeting
West china hospital
Rashid sayyid
Urologic oncology
Clinical fellow
Advanced adrenocortical
ASCO 2024:A Multi-Institution Analysis of Outcomes With First-Line Systemic Therapy for 102 Patients With Metastatic Chromophobe Renal Cell Carcinoma
metastatic chromophobe RCC patients receiving 1st line systemic therapy, first-line systemic therapy for metastatic chromophobe renal cell carcinoma (RCC).
United states
New york
Johns hopkins
Sahil doshi
University of toronto
American society of clinical oncology
Society of urologic oncology
Clinical oncology
Annual meeting
Hematology fellow
Memorial sloan kettering cancer center
Rashid sayyid
Urologic oncology
Clinical fellow
ASCO 2024: Advanced Sequencing and Targeted Therapy Strategies in Renal Cell Carcinoma: How Can We Help More Patients Not at the Expense of Toxicity?
ASCO 2024 diagnostic and therapeutic strategies in renal cell carcinoma (RCC), vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).
San diego
United states
United kingdom
Belzutifan welireg
Yu wei chen
Laurence albiges
Department of medicine
Society of urologic oncology
University of california
American society of clinical oncology
University of toronto
San diego medical center
National cancer database
Clinical oncology
Annual meeting
Hypoxia inducible factor
ASCO 2024: Avelumab as Neoadjuvant Therapy in Patients with Muscle-Invasive Urothelial Carcinoma: Survival Data of AURA Trial, Oncodistinct 004
ASCO 2024, Muscle-Invasive Urothelial Carcinoma, Muscle invasive bladder cancer (MIBC), Avelumab, Avelumab as Neoadjuvant Therapy, AURA Trial, Oncodistinct 004.
Bruxelles capitale
United states
Institut jules bordet
Jeremy blanc
University of toronto
Society of urologic oncology
American society of clinical oncology
Clinical oncology
Annual meeting
Universitaire de bruxelles
Libre de bruxelles
Rashid sayyid
Urologic oncology
Clinical fellow
Neoadjuvant therapy before radical cystectomy
NEW MAZDA SPONSORED SURVEY FINDS NEARLY HALF OF CAR-SHARING AMERICAN COUPLES HAVE MONTHLY VEHICLE DISAGREEMENTS
/PRNewswire/ Mazda North American Operations (MNAO) is revealing what could be driving arguments with couples when it comes to their vehicles. While.
Mexico city
Distrito federal
United states
Richmond hill
New york
Insidemazda mazda
Elizabeth earnshaw
American association of marriage family therapy
New york times
Mazda canada inc
Washington post
Talker research
Key survey data points
Key survey data
North american operations
Driver personalization
vimarsana © 2020. All Rights Reserved.